Login / Signup

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans.

Christine M HuntJimmy T EfirdThomas S ReddingAndrew D ThompsonAshlyn M PressChristina D WilliamsChristopher J HostlerAyako Suzuki
Published in: Journal of general internal medicine (2022)
In this large national cohort, treatment of SARS-CoV-2 positive patients with individual or co-prescribed metformin and statins, ACEi and statins (or metformin) and other medications was associated with a markedly decreased 30-day mortality and can likely be continued safely. Clinical trials may assess their therapeutic benefit.
Keyphrases
  • sars cov
  • clinical trial
  • cardiovascular disease
  • cardiovascular events
  • respiratory syndrome coronavirus
  • risk factors
  • type diabetes
  • phase ii
  • double blind
  • smoking cessation